Comments on: "Antinuclear antibodies as a risk factor for ischemic stroke or death in elderly patients with atrial fibrillation despite anticoagulation".

IF 2.8 3区医学 Q2 RHEUMATOLOGY

Clinical Rheumatology Pub Date : 2025-10-06 DOI:10.1007/s10067-025-07721-4

Nedim Kaban, Yusuf Hosoglu

引用次数: 0

查看原文本刊更多论文

评论：“尽管抗凝，抗核抗体仍是老年房颤患者缺血性卒中或死亡的危险因素”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Rheumatology 医学-风湿病学

CiteScore

6.90

自引率

2.90%

发文量

441

审稿时长

3 months

期刊介绍： Clinical Rheumatology is an international English-language journal devoted to publishing original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level. The journal succeeds Acta Rheumatologica Belgica, originally founded in 1945 as the official journal of the Belgian Rheumatology Society. Clinical Rheumatology aims to cover all modern trends in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures connected with the inflammatory, immunologic, metabolic, genetic and degenerative soft and hard connective tissue diseases.